Pathway Financial Advisers’s Medtronic MDT Stock Holding History

Pathway Financial Advisers’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.71M	Sell	19,748 -18,843	-49%	-$1.81M	0.48%	72
2025 Q4	$3.71M	Sell	38,591 -563	-1%	-$54.7K	1.07%	31
2025 Q3	$3.72M	Sell	39,154 -423	-1%	-$38.9K	1.08%	29
2025 Q2	$3.45M	Sell	39,577 -552	-1%	-$46.8K	1.12%	29
2025 Q1	$3.61M	Buy	40,129 +324	+0.8%	+$29K	1.24%	27
2024 Q4	$3.18M	Sell	39,805 -832	-2%	-$72K	1.07%	30
2024 Q3	$3.66M	Buy	40,637 +1,216	+3%	+$102K	1.66%	19
2024 Q2	$3.09M	Buy	39,421 +868	+2%	+$71.2K	1.11%	27
2024 Q1	$3.36M	Buy	38,553 +2,557	+7%	+$218K	1.21%	24
2023 Q4	$2.97M	Sell	35,996 -163	-0.5%	-$12.4K	1.13%	27
2023 Q3	$2.83M	Buy	+36,159	New	+$3.03M	1.17%	28
2023 Q1	$2.66M	Buy	32,999 +7,882	+31%	+$642K	1.07%	29
2022 Q4	$1.95M	Buy	+25,117	New	+$2.04M	0.79%	44

Other funds holding MDT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Pathway Financial Advisers's MDT Position: Q1 2026 in Review

Pathway Financial Advisers reduced its Medtronic (MDT) stake by 49% in Q1 2026, selling an estimated $1.81M and leaving 19,748 shares worth $1.71M. The position accounts for 0.48% of the portfolio, ranked #72.

Pathway Financial Advisers first reported a position in MDT in Q4 2022 and has held it in 13 quarters since. The position peaked at $3.72M in Q3 2025. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

Pathway Financial Advisers held 19,748 shares of Medtronic worth $1.71M as of Q1 2026.
Pathway Financial Advisers sold 18,843 Medtronic shares in Q1 2026, an estimated $1.81M.
Medtronic made up 0.48% of Pathway Financial Advisers's portfolio in Q1 2026, its #72 holding.
Pathway Financial Advisers first reported a position in Medtronic in Q4 2022 and has held it in 13 quarters since.
Pathway Financial Advisers's Medtronic position peaked at $3.72M in Q3 2025.
2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Pathway Financial Advisers's 13F filing for Q1 2026, filed 23 Apr 2026.